Prevalence and risk factors of cardiovascular diseases in patients with IgA nephropathy and diabetic nephropathy
WU Yan,LIANG Dan-dan,YANG Liu,LI Juan,ZUO Ke,ZHOU Yu-chao,LIU Zhi-hong
DOI: https://doi.org/10.3969/j.issn.1006-298X.2012.03.002
2012-01-01
Abstract:Objective:To investigate the prevalence and the risk factors for cardiovascular diseases (CVD) in patients with IgA nephropathy (IgAN) and diabetic nephropathy (DN) CKD stage 2～5. Methodology:One hundred and eighty-one patients with IgAN and 199 patients with DN,who were biopsy-proven and hospitalized or followed in our Nephrology Department, were surveyed by collecting history and laboratory data. Logistic regression analysis was used to evaluate the association of clinical data with CVD events. Results:The prevalence of CVD in patients with IgAN CKD stage 2～5 were 8.7%,7.7%,17.2% and 44.4% respectively.The prevalence of CVD in patients with DN CKD stage 2～5 were 29.6%,40.0%,45.2% and 72.7% respectively. The prevalence of CVD in the each CKD stage patients with DN were significantly increased when compared with the patients with IgAN (CKD stage 2 29.6% vs 8.7%,P<0.01,CKD stage 3 40.0% vs 7.7%,P<0.01,CKD stage 4 45.2% vs 17.2%,P<0.05,CKD stage 5 72.7% vs 44.4%,P<0.05). The total prevalence of CAD and LVH in the patients with DN were markedly elevated as compared with the patients with IgAN, and the difference in CAD between two diseases was the most significant (CAD 16.1% vs 0.6%,P<0.01,LVH 33.2% vs 14.7%,P<0.01).The prevalence of CVD in the patients of both diseases with CKD stage 5 was remarkably higher than that in the patients with CKD stage 2～4. In the patients with IgAN, the incidence of hypertension, the levels of SCr and serum phosphate in patients with CVD were significantly elevated and the level of Hb was decreased as compared with the patients without CVD. In the patients with DN, the incidence of smoking history, hypertension, the levels of SCr and TC in patients with CVD were significantly increased as compared with the patients without CVD. Logistic regression analysis showed that the independent risk factors of LVH for patients with both kidney diseases, and CAD for patients with DN were SCr and Hb (OR values were 1.22,P<0.05 and 0.67,P<0.01),SCr and BMI (OR values were 1.77,P<0.01;1.36,P<0.05), and smoking history,SCr and LDL respectively (OR values were 2.96,P<0.05;1.45,P<0.01;6.93,P<0.05). Conclusion:The prevalence of CVD in the each CKD stage patients with DN was higher than that in patients with IgAN and LVH is the commonest manifestation of CVD in the patients with both diseases. The prevalence of CAD and LVH in the patients with DN was higher than that in the patients with IgAN, which suggests the correlation with higher CVD mortality in the patients with DN. The prevalence of CVD in the patients of both diseases with CKD stage 5 was remarkably increasing, indicating the early intervention in CKD patients is necessary. Kidney specific risk factors play an important role in CVD patients with IgAN, and diabetic related and other metabolism risk factors may exert a larger influence over kidney specific factors in CVD patients with DN.